| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |